ImmuneSpec offers MHC-associated peptide proteomics (MAPPs) as a specialized service. Leveraging a state-of-the-art immunopeptidomics platform, ImmuneSpec enables rapid and reliable identification of immunogenic peptides, precisely mapping the peptide regions that trigger an immune response.
Key applications include testing of biologics for unwanted immunogenicity, pinpointing immunogenic areas for the development of broad-spectrum vaccines and identification of neo-antigens for the generation of leads suitable for immunotherapy.